₹194.55
+₹2.05 (+1.06%)
Closed · As of 26 Aug 3:30 pm
Mkt Cap
₹930 Cr
P/E
37.26
ROE
4.85%
ROCE
6.56%
About Kopran Ltd
Kopran is engaged in the business of manufacturing of Formulation (Finished Dosage Form).
Founded
1958
CEO
Susheel G Somani
Employees
1,024
HQ
Mumbai, Maharashtra
About Kopran Ltd
Kopran is engaged in the business of manufacturing of Formulation (Finished Dosage Form).
Founded:1958
CEO:Susheel G Somani
Employees:1,024
HQ:Mumbai, Maharashtra
Finished Products
1Sale of Products
₹868.51Cr2Service
₹6.27Cr3Export Incentives
₹5.46Cr4Sal of Scrap
₹1.32CrRaw Materials
1Raw Material Consumed
₹487.34Cr2Purchases of Stock in Trade
₹36.73Cr3Packing Materials Consumed
₹21.24Cr4Purchase of Finished Goods
₹19.94CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹219
52W Low
₹107
Volume31.70K
Avg VolumeN/A
Beta1.43
Dividend Yield1.56%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
37.26x
Valuation
P/B Ratio
1.75x
Valuation
EPS
₹5.17
Valuation
Dividend Yield
1.56%
Valuation
ROE
4.85%
Profitability
ROCE
6.56%
Profitability
Revenue by Segment
Contribution & growth by business line
Bulk Drugs
+30.9%54.1%
₹330.04 Cr
Pharmaceuticals
+10.6%45.7%
₹278.56 Cr
Others
-96.6%0.2%
₹1.49 Cr
Geographical Revenue Split
Domestic vs international exposure
Domestic
32.4%
International
67.6%
In India32.4%
Rest of World23.4%
South Africa18.4%
Ethiopia6.5%
United Kingdom4.6%
Bangladesh3.9%
Strategic Relations
Collaborations, joint ventures & subsidiaries
G
Gesellschaft Fur Biotechnologische For. Gmbh
Germany
0.00% stakeY
Yuhan Corporation
South Korea
0.00% stakeC
Ciba Corning Diagnostics
United States
0.00% stakeA
Adac Laboratories
United States
0.00% stakeForensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
0.29x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
3.5%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.